eIF4A inhibition prevents the onset of cytokine-induced muscle wasting by blocking the STAT3 and iNOS pathways
<div><p>Cachexia is a deadly muscle wasting syndrome that arises under conditions linked to chronic inflammation, such as cancer. Cytokines, including interferon γ (IFNγ), tumor necrosis factor α (TNFα) and interleukin-6 (IL-6), and their downstream effectors such as Signal Transducer an...
محفوظ في:
| المؤلف الرئيسي: | Zvi Cramer (10742876) (author) |
|---|---|
| مؤلفون آخرون: | Jason Sadek (18629365) (author), Gabriela Galicia Vazquez (18697006) (author), Sergio Di Marco (387749) (author), Arnim Pause (265677) (author), Jerry Pelletier (28518) (author), Imed-Eddine Gallouzi (387751) (author) |
| منشور في: |
2018
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Human IRF1 governs macrophagic IFN-γ immunity to mycobacteria
حسب: Jérémie Rosain (5900399)
منشور في: (2023) -
The trans-10, cis-12 isomer of conjugated linoleic acid decreases adiponectin assembly by PPARγ-dependent and PPARγ-independent mechanisms
حسب: Miller, Jessica R.
منشور في: (2008) -
Novel thiazolones for the simultaneous modulation of PPARγ, COX-2 and 15-LOX to address metabolic disease-associated portal inflammation
حسب: Mai S., El-Shoukrofy
منشور في: (2025) -
Novel thiazolones for the simultaneous modulation of PPARγ, COX-2 and 15-LOX to address metabolic disease-associated portal inflammation
حسب: Mai S. El-Shoukrofy (19646815)
منشور في: (2025) -
The AMPK agonist 5‐aminoimidazole‐4‐carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation‐associated cachectic muscle wasting
حسب: Derek T Hall (18629356)
منشور في: (2018)